Inhibition of the striatal specific phosphodiesterase PDE10A ameliorates striatal and cortical pathology in R6/2 mouse model of Huntington's disease.
<h4>Background</h4>Huntington's disease is a devastating neurodegenerative condition for which there is no therapy to slow disease progression. The particular vulnerability of striatal medium spiny neurons to Huntington's pathology is hypothesized to result from transcriptional...
Guardado en:
Autores principales: | Carmela Giampà, Daunia Laurenti, Serenella Anzilotti, Giorgio Bernardi, Frank S Menniti, Francesca Romana Fusco |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8bb4ad0208bb4007b0bdcdbb45561208 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington’s disease
por: Zheng Wu, et al.
Publicado: (2020) -
Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models
por: Matthew P. Parsons, et al.
Publicado: (2016) -
Global and local excitation and inhibition shape the dynamics of the cortico-striatal-thalamo-cortical pathway
por: Anca Rădulescu, et al.
Publicado: (2017) -
Increased striatal activity in adolescence benefits learning
por: S. Peters, et al.
Publicado: (2017) -
Knowledge acquisition is governed by striatal prediction errors
por: Alex Pine, et al.
Publicado: (2018)